Close Menu

NEW YORK (GenomeWeb) – Switzerland's mandatory health insurance (OKP) will reimburse noninvasive prenatal trisomy screening for certain high-risk pregnancies starting July 15, the Swiss Federal Department of Home Affairs (EDI) said today.

OKP will pay for NIPT if standard first trimester screening — a combination of biochemical blood tests and nuchal translucency analysis — indicates a risk higher than 1:1000 for fetal trisomies 21, 18, or 13.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.

Sponsored by

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.